These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28043942)

  • 1. A Cognitive Turning Point in Development of Clinical Alzheimer's Disease Dementia and Mild Cognitive Impairment: A Biracial Population Study.
    Rajan KB; Wilson RS; Barnes LL; Aggarwal NT; Weuve J; Evans DA
    J Gerontol A Biol Sci Med Sci; 2017 Mar; 72(3):424-430. PubMed ID: 28043942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race, APOEɛ4, and Long-Term Cognitive Trajectories in a Biracial Population Sample.
    Rajan KB; McAninch EA; Wilson RS; Weuve J; Barnes LL; Evans DA
    J Alzheimers Dis; 2019; 72(1):45-53. PubMed ID: 31561363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive decline following incident and preexisting diabetes mellitus in a population sample.
    Rajan KB; Arvanitakis Z; Lynch EB; McAninch EA; Wilson RS; Weuve J; Barnes LL; Bianco AC; Evans DA
    Neurology; 2016 Oct; 87(16):1681-1687. PubMed ID: 27655734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Common DIO2 Polymorphism and Alzheimer Disease Dementia in African and European Americans.
    McAninch EA; Rajan KB; Evans DA; Jo S; Chaker L; Peeters RP; Bennett DA; Mash DC; Bianco AC
    J Clin Endocrinol Metab; 2018 May; 103(5):1818-1826. PubMed ID: 29481662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet as a Risk Factor for Cognitive Decline in African Americans and Caucasians with a Parental History of Alzheimer's Disease: A Cross-Sectional Pilot Study Dietary Patterns.
    Nutaitis AC; Tharwani SD; Serra MC; Goldstein FC; Zhao L; Sher SS; Verble DD; Wharton W
    J Prev Alzheimers Dis; 2019; 6(1):50-55. PubMed ID: 30569086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia.
    Rajan KB; Wilson RS; Weuve J; Barnes LL; Evans DA
    Neurology; 2015 Sep; 85(10):898-904. PubMed ID: 26109713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging Audiences: Association of Live Performance Attendance and Cognitive Decline in a Biracial Sample.
    Rajan KB; Rajan RS; Manning LK; Evans DA
    J Aging Health; 2018 Mar; 30(3):445-457. PubMed ID: 28553789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.
    Howell JC; Watts KD; Parker MW; Wu J; Kollhoff A; Wingo TS; Dorbin CD; Qiu D; Hu WT
    Alzheimers Res Ther; 2017 Nov; 9(1):88. PubMed ID: 29096697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive Aging in Black and White Americans: Cognition, Cognitive Decline, and Incidence of Alzheimer Disease Dementia.
    Weuve J; Barnes LL; Mendes de Leon CF; Rajan KB; Beck T; Aggarwal NT; Hebert LE; Bennett DA; Wilson RS; Evans DA
    Epidemiology; 2018 Jan; 29(1):151-159. PubMed ID: 28863046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans.
    Zhang P; Hou Y; Tu W; Campbell N; Pieper AA; Leverenz JB; Gao S; Cummings J; Cheng F
    Alzheimers Dement; 2023 May; 19(5):1876-1887. PubMed ID: 36331056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older Patients with Alzheimer's Disease-Related Cortical Atrophy Who Develop Post-Operative Delirium May Be at Increased Risk of Long-Term Cognitive Decline After Surgery.
    Racine AM; Touroutoglou A; Abrantes T; Wong B; Fong TG; Cavallari M; Travison TG; Gou Y; Marcantonio ER; Alsop DC; Jones RN; Inouye SK; Dickerson BC;
    J Alzheimers Dis; 2020; 75(1):187-199. PubMed ID: 32250290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment.
    Cloutier S; Chertkow H; Kergoat MJ; Gauthier S; Belleville S
    J Alzheimers Dis; 2015; 47(4):901-13. PubMed ID: 26401770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MGEKN; Tabet N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease.
    Langbaum JB; Ellison NN; Caputo A; Thomas RG; Langlois C; Riviere ME; Graf A; Lopez Lopez C; Reiman EM; Tariot PN; Hendrix SB
    Alzheimers Res Ther; 2020 May; 12(1):66. PubMed ID: 32460855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.
    Liu-Seifert H; Siemers E; Price K; Han B; Selzler KJ; Henley D; Sundell K; Aisen P; Cummings J; Raskin J; Mohs R;
    J Alzheimers Dis; 2015; 47(1):205-14. PubMed ID: 26402769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of Cognitive Change in Preclinical and Prodromal Alzheimer's Disease Using Change-Point Analysis.
    Williams OA; An Y; Armstrong NM; Kitner-Triolo M; Ferrucci L; Resnick SM
    J Alzheimers Dis; 2020; 75(4):1169-1180. PubMed ID: 32390623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A random change point model for cognitive decline in Alzheimer's disease and mild cognitive impairment.
    Yu L; Boyle P; Wilson RS; Segawa E; Leurgans S; De Jager PL; Bennett DA
    Neuroepidemiology; 2012; 39(2):73-83. PubMed ID: 22814083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Souvenaid for Alzheimer's disease.
    Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.